Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.

By aguda y crónica. Revista Española de Cardiología, 2022

3,271 citations recorded by the source corpus.

The guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) for 2021 are an update on the previous guidelines from 5 years previously (2016). These guidelines have been eagerly anticipated due to the need to respond with practical recommendations to the high number of scientific publications that have since been released. However, the lack of agility of these guidelines is precisely their main weakness. Thus, the document has unfortunately not considered the simultaneous publication of new evidence on the management of HF with preserved left ventricular ejection fraction (LVEF) (HFpEF). Although the guidelines are a scientific tool for improving the diagnosis and treatment of our patients, continuous updating of their recommendations is clearly required to keep them current. The purpose of the present article is to highlight the most relevant novelties of the new guidelines and to comment on those aspects that, from a Spanish perspective, could improve understanding and local application. To do so, we address various sections of the text and include table 1 and figure 1 as summaries.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/517fdab3126f683f6a4147f65fa746fbc98a2dbe